Clarity Pharmaceuticals Ltd Asymmetric ILLIQ Liquidity Analysis
High-persistence model: shocks decay very slowly, so the theoretical long-run value may not be practically meaningful
Liquidity prediction for Friday, July 10th, 2026
1 Day
4,919.36
decreased by 518.55
1 Week
5,851.88
increased by 413.97
1 Month
5,022.37
decreased by 415.54
Analysis last updated: Friday, July 10, 2026 at 06:16 PM UTC
News Impact Curve
How returns affect tomorrow's liquidityLiquidity Forecast
How liquidity evolves over timeParameter Estimates
Aug 25, 2021 to Jul 3, 2026Model Insight
Estimated persistence of 1.000 is at or above 1 (non-stationary): illiquidity shocks do not decay and the long-run level is undefined, so long-horizon forecasts should be treated with caution.
μ
ILLIQ-AMEM Model
Tap to view equation
| Parameter | Value | t-statistic |
|---|---|---|
ω const Unconditional variance weight | 5.0000 | 0.09 |
α ARCH Response to squared shocks | 0.2868 | 1.61 |
β GARCH Volatility persistence | 0.7110 | 10.63*** |
γ leverage Additional response to negative shocks | 0.0044 | 0.02 |
Persistence:
1.000
Half-life:
-
Other Clarity Pharmaceuticals Ltd Analyses
Other Asymmetric ILLIQ Analyses on International Equities